Physiomics Plc (PYC) – Company Profile and SWOT Analysis

Physiomics Plc (PYC) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Physiomics Plc (Physiomics) provides consulting services to pharmaceutical companies in the areas of computational biology and quantitative pharmacology. The company’s proprietary technology platform, Virtual Tumour, uses computer modeling to predict the effects of cancer drugs and treatments. Physiomics offers model-based drug development services, which include population (Pharmacokinetics and Pharmacodynamics) PKPD analysis of clinical data, back-translational analysis, and optimal design of future studies. It also has Quantitative Systems Pharmacology which involves the combination of PK/PD of a therapeutic agent with the mechanistic model and a large quantitative experimental drug data. Physiomics is headquartered in Oxfordshire, the UK.

Scope

• Detailed information on Physiomics Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Physiomics Plc in the form of a SWOT analysis

• An in-depth view of the business model of Physiomics Plc including a breakdown and examination of key business segments

• News about Physiomics Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Physiomics Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Physiomics Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Physiomics Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Avacta Group Plc

Proteome Sciences Plc

IXICO Plc

Tangram Therapeutics Plc

Cyprotex Ltd

Elekta AB

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Physiomics Plc - Key Facts

Physiomics Plc - Key Employees

Physiomics Plc - Key Employee Biographies

Physiomics Plc - Major Products and Services

Physiomics Plc - History

Physiomics Plc - Company Statement

Physiomics Plc - Locations And Subsidiaries

Head Office

Section 2 – Company Analysis

Company Overview

Physiomics Plc - Business Description

Physiomics Plc - Corporate Strategy

Physiomics Plc - SWOT Analysis

SWOT Analysis - Overview

Physiomics Plc - Strengths

Physiomics Plc - Weaknesses

Physiomics Plc - Opportunities

Physiomics Plc - Threats

Physiomics Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Physiomics Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 16, 2026: Physiomics Announces Interim Results for the Six-Month Period Ended 31 December 2025

Feb 16, 2026: Physiomics Announces Interim Results Statement for the six-month period ended 31 December 2025

Feb 12, 2026: Physiomics PLC Physiomics Awarded New Contract

Jan 28, 2026: Physiomics Awarded New Contract by Numab Therapeutics

Dec 15, 2025: Physiomics Awarded Follow On Contract by UK Client

Dec 11, 2025: Physiomics PLC Physiomics Awarded New Contract by Numab

Dec 10, 2025: Physiomics Awarded New Contract by GARDP FOUNDATION

Dec 04, 2025: Physiomics Awarded Two New Contracts

Dec 03, 2025: Physiomics : Board Changes

Sep 30, 2025: Physiomics Announces Change of Registered Office

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Physiomics Plc, Key Facts

Physiomics Plc, Key Employees

Physiomics Plc, Key Employee Biographies

Physiomics Plc, Major Products and Services

Physiomics Plc, History

Physiomics Plc, Key Competitors

Physiomics Plc, Ratios based on current share price

Physiomics Plc, Annual Ratios

Physiomics Plc, Annual Ratios (Cont…1)

Physiomics Plc, Interim Ratios

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Physiomics Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Physiomics Plc, Performance Chart (2021 – 2025)

Physiomics Plc, Ratio Charts

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports